| Toll-like receptor 9 agonists in cancer L Karapetyan, JJ Luke, D Davar OncoTargets and therapy, 10039-10060, 2020 | 95 | 2020 |
| Molecular pathways and mechanisms of LAG3 in cancer therapy LP Andrews, AR Cillo, L Karapetyan, JM Kirkwood, CJ Workman, ... Clinical Cancer Research 28 (23), 5030-5039, 2022 | 49 | 2022 |
| Immunotherapy in melanoma: recent advances and future directions A Knight, L Karapetyan, JM Kirkwood Cancers 15 (4), 1106, 2023 | 48 | 2023 |
| The wearable cardioverter defibrillator in nonischemic cardiomyopathy: a US national database analysis N Salehi, M Nasiri, NR Bianco, M Opreanu, V Singh, V Satija, AS Jhand, ... Canadian Journal of Cardiology 32 (10), 1247. e1-1247. e6, 2016 | 33 | 2016 |
| Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced … WJ Storkus, D Maurer, Y Lin, F Ding, A Bose, D Lowe, A Rose, M DeMark, ... Journal for immunotherapy of cancer 9 (11), 2021 | 29 | 2021 |
| A case of acquired haemophilia A in a 70‐year‐old post COVID‐19 vaccine C Lemoine, AG Giacobbe, E Bonifacino, L Karapetyan, C Seaman Haemophilia, 2021 | 20 | 2021 |
| An overview of the toxicities of checkpoint inhibitors in older patients with cancer O Alkharabsheh, P Kannarkatt, J Kannarkatt, L Karapetyan, HS Laird-Fick, ... Journal of Geriatric Oncology 9 (5), 451-458, 2018 | 19 | 2018 |
| Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation MJ Awan, P Lavertu, C Zender, R Rezaee, N Fowler, L Karapetyan, ... European journal of nuclear medicine and molecular imaging 44, 988-997, 2017 | 18 | 2017 |
| Association of Germline PALB2 Mutation and Response to Platinum-Based Chemotherapy in Metastatic Breast Cancer: A Case Series D Isaac, L Karapetyan, D Tamkus JCO Precision Oncology 2, 1-5, 2018 | 15 | 2018 |
| Indoor tanning exposure in association with multiple primary melanoma L Karapetyan, X Yang, H Wang, CA Sander, A Moyer, M Wilson, ... Cancer 127 (4), 560-568, 2021 | 9 | 2021 |
| Early detection and prognostic assessment of cutaneous melanoma: consensus on optimal practice and the role of gene expression profile testing M Kashani-Sabet, SA Leachman, JA Stein, JL Arbiser, EG Berry, ... JAMA dermatology 159 (5), 545-553, 2023 | 8 | 2023 |
| Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases MC Korpics, BE Onderdonk, RE Dadey, JH Hara, L Karapetyan, Y Zha, ... The Journal of Clinical Investigation 133 (10), 2023 | 5 | 2023 |
| Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma AAFMKG Harry Yoona, Lilit Karapetyan, Anita Choudhary, Ramla Kosozi ... The Oncologist 23 (6), 2018 | 5 | 2018 |
| Metastatic invasive lobular breast cancer presenting clinically with esophageal dysphagia L Karapetyan, H Laird-Fick, R Cuison Case Reports in Oncological Medicine 2017, 2017 | 5 | 2017 |
| Case report: single dose anti-PD1 in a patient with metastatic melanoma and cardiac allograft AE Goodman, L Karapetyan, M Pugliano-Mauro, JE Levenson, JJ Luke Frontiers in Immunology 12, 660795, 2021 | 4 | 2021 |
| State of melanoma: an historic overview of a field in transition L Karapetyan, JM Kirkwood Hematology/Oncology Clinics 35 (1), 1-27, 2021 | 4 | 2021 |
| Sarcoidosis and monoclonal gammopathy of undetermined significance (MGUS): a true association or just a coincidence? M Hassanein, L Karapetyan, A Khan, S Rayamajhi Case Reports in Hematology 2018, 2018 | 4 | 2018 |
| End-Of-Life care for an undocumented Mexican immigrant: resident perspective L Karapetyan, O Dawani, HS Laird-Fick Journal of Palliative Care 33 (2), 63-64, 2018 | 4 | 2018 |
| Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations L Karapetyan, UK Iheagwara, AC Olson, SJ Chmura, HK Skinner, JJ Luke JNCI: Journal of the National Cancer Institute 115 (11), 1278-1293, 2023 | 3 | 2023 |
| Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes L Karapetyan, HM AbuShukair, A Li, A Knight, AN Al Bzour, IP MacFawn, ... Frontiers in Immunology 14, 1171978, 2023 | 3 | 2023 |
